These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3707109)

  • 1. Activity of coumermycin against clinical isolates of staphylococci.
    Guillemin MN; Miles HM; McDonald MI
    Antimicrob Agents Chemother; 1986 Apr; 29(4):608-10. PubMed ID: 3707109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
    Thomas MG; Lang SD
    J Antimicrob Chemother; 1986 Aug; 18(2):171-5. PubMed ID: 3639086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
    Meyers BR; Srulevitch ES; Hirschman SZ
    Antimicrob Agents Chemother; 1985 Nov; 28(5):706-7. PubMed ID: 3853964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
    Hirschl AM; Georgopoulos A; Stanek G; Breyer S; Rotter ML
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):541-8. PubMed ID: 3164157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
    Aldridge KE; Janney A; Sanders CV
    Antimicrob Agents Chemother; 1985 Nov; 28(5):634-8. PubMed ID: 2936300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of methicillin resistant staphylococci for susceptibility to coumermycin.
    Thomas MG; Lang SD
    J Antimicrob Chemother; 1985 Nov; 16(5):675-6. PubMed ID: 3852835
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
    Van der Auwera P; Klastersky J
    Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
    Digranes A; Salveson A; Dibb WL
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):85-8. PubMed ID: 3728027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
    Foster JK; Lentino JR; Strodtman R; DiVincenzo C
    Antimicrob Agents Chemother; 1986 Dec; 30(6):823-7. PubMed ID: 3643771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
    Smith SM; Eng RH
    Antimicrob Agents Chemother; 1985 May; 27(5):688-91. PubMed ID: 3160301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of the activity of coumermycin-A1 against staphylococci resistant to methicillin and cephalothin.
    Michaeli D; Meyers B; Weinstein L
    J Infect Dis; 1969 Oct; 120(4):488-90. PubMed ID: 5195766
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
    Varaldo PE; Debbia E; Schito GC
    J Antimicrob Chemother; 1984 Dec; 14 Suppl D():35-41. PubMed ID: 6569872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN; Barry AL; Gardiner RV; Packer RR
    Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of coumermycin alone and in combination with other antibiotics.
    Neu HC; Chin NX; Labthavikul P
    Antimicrob Agents Chemother; 1984 Jun; 25(6):687-9. PubMed ID: 6331295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of antimicrobial resistance in staphylococci.
    Thornsberry C
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():9-17. PubMed ID: 3290186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of coumermycin in comparison to other non-beta-lactam antibiotics against staphylococci, streptococci, and Clostridium difficile.
    Mittermayer H
    Chemioterapia; 1987 Jun; 6(2 Suppl):163-4. PubMed ID: 3509379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.